Homoeopathic Antimiasmatic Medicines In The Treatment Of Generalised Anxiety Disorder
Phase 4
- Conditions
- Health Condition 1: F411- Generalized anxiety disorder
- Registration Number
- CTRI/2023/03/050941
- Lead Sponsor
- Smija janardhanan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Both male and female patients are included
Age group 18 to 40 years
Exclusion Criteria
Patients with active treatment for any other chronic diseases like hypertension,diseases of thyroid,cardiovascular diseases
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Diagnosis based on clinical presentation such as problems sleeping,difficulties with concentration ,angry outbursts, <br/ ><br>Hamilton anxiety scaleTimepoint: At baseline and after 6 months
- Secondary Outcome Measures
Name Time Method It is expected that the proposed study will be useful in reducing the symptoms of generalised anxiety disorderTimepoint: At baseline and after six months